BioMed Diagnostics to Attend VMX 2024
Tuesday, January 9th, 2024
Available for Meetings with Veterinary Professionals
ORLANDO, Fla.—BioMed Diagnostics, a leader in microbiological testing and a DCN Dx brand, is pleased to announce their attendance at VMX 2024, the world’s leading veterinary expo and conference. While not exhibiting, BioMed representatives have set aside availability for meeting with veterinary professionals and attendees throughout the event.
This year’s VMX, held from January 13 to 17 at the Orange County Convention Center in Orlando, Fla., is an ideal venue for BioMed to engage directly with veterinarians, veterinary nurses/technicians, practice managers, and other members of the veterinary community.
BioMed specializes in innovative, user-friendly testing tools for detecting infectious microorganisms in humans, animals, food, and the environment. Their unique products streamline the processes of specimen collection, culture, and transport into a single device, offering impactful health solutions across various sectors.
Highlighting their commitment to veterinary health, BioMed representatives will discuss several key products at VMX 2024, including:
- InTray® DM: An enriched dermatophyte medium for detecting dermatophytes from clinical specimens. Features a single exposure system with dynamic built-in components for user compatibility and ease of detection. More about InTray® DM.
- InPouch® TF-Feline: A highly selective prepared-culture media device for detecting feline Tritrichomonas foetus. Known for its cost-effectiveness and ease of use, this broth media device increases specificity by inhibiting growth of yeasts, molds, bacteria, and other micro-flora. More about InPouch® TF-Feline.
- InTray® VS COLOREXTM Screen: The major target is the detection of urinary tract pathogens, but COLOREXTM Screen has a broader application as a general nutrient agar for the isolation of various microorganisms. It can also be used to differentiate various microorganisms in other infected areas (e.g., scars, wounds). More about InTray® VS COLOREXTM Screen.
Veterinary professionals interested in learning more about how BioMed’s products can benefit their practices are encouraged to schedule a meeting during VMX 2024. To arrange a meeting, please visit BioMed’s meeting request form.
“We're excited to join VMX 2024 and connect with veterinary professionals," said Mitzi Rettinger, Chief Revenue Officer at DCN Dx. "BioMed’s range of diagnostic tools are designed to improve testing accuracy and efficiency in veterinary practices. Meeting face-to-face with experts and practitioners at VMX allows us to better understand and meet the evolving needs of the veterinary community."
VMX 2024 promises to be an extraordinary event, featuring over 1,200 hours of continuing education, numerous program tracks, and extensive networking opportunities. BioMed Diagnostics is excited to be a part of this dynamic gathering, connecting with peers and exploring the latest advancements in veterinary medicine.
About Biomed Diagnostics, a DCN Dx Brand
Biomed Diagnostics, a DCN Dx brand, is a pioneer in microbiological testing. It develops innovative, user-friendly tools that detect infectious microorganisms in humans, animals, food, and the environment. The company's InTray and InPouch formats streamline the processes of specimen collection, culture, and transport into a single device. Biomed Diagnostics is committed to impactful health solutions in veterinary, human health, food safety, and environmental markets.
For more information, visit biomeddiagnostics.com.
About DCN Dx
DCN Dx, based in Carlsbad, California, is a global leader in IVD CDMO and CRO services. Our multidisciplinary team specializes in creating tailored assay systems, consumables, and instruments for point-of-use applications, with a particular expertise in lateral flow assays.
Our personalized approach to IVD product development has supported more than 560 programs from over 260 clients. We can oversee every stage from concept to assay development and platform integration, through clinical trials to manufacturing or only handle the aspects you request. In addition to lateral flow assays, our clinical research expertise extends to a wide range of IVD devices, all with a focus on innovation, usability, and performance.
With a commitment to quality, customer satisfaction, and industry-leading expertise, DCN Dx is setting the benchmark for excellence in IVD services. To learn more about how we can support your diagnostic needs, visit dcndx.com.